Zagreb, Croatia

Kata Majerski

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Rudjer Boskovic Institute. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kata Majerski. Retrieved from https://idiyas.com/inventor/kata-majerski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kata Majerski: Innovator in Tumor Treatment and Anion Sensing

Introduction

Kata Majerski is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of chemistry, particularly in the development of innovative compounds for medical and analytical applications. With a total of 2 patents, his work showcases the intersection of chemistry and practical solutions for health and environmental challenges.

Latest Patents

Majerski's latest patents include "Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor" and "Adamantane-dipyrromethane derivatives, method of preparation and applications in anion sensing." The first patent focuses on adamantane diaza-crown ether derivatives, which have shown potential in treating tumors. These compounds were synthesized through the reaction of adamantane-derived tosylates or acid chlorides with mono- and diaza-18-crown-6. The resulting compounds exhibited varying degrees of antiproliferative and cytotoxic activity against several tumor cell lines, indicating their potential for inhibiting tumor growth.

The second patent involves the preparation of adamantane dipyrromethane derivatives, which are created by reacting adamantane carbonyl derivatives with pyrrole or its derivatives in the presence of acid. These derivatives are particularly effective in binding anions such as fluoride, chloride, bromide, acetate, hydrogen sulfate, nitrate, and dihydrogen phosphate, with a notable affinity for fluoride ions.

Career Highlights

Kata Majerski is affiliated with the Ruđer Bošković Institute, where he conducts his research and development activities. His work has contributed to advancements in both medicinal chemistry and analytical methods, reflecting his commitment to innovation in science.

Collaborations

Majerski collaborates with talented colleagues, including Marijeta Kralj and Tatjana Sumanovac Ramljak. These partnerships enhance the research environment and foster the development of groundbreaking solutions in their respective fields.

Conclusion

Kata Majerski's contributions to the fields of tumor treatment and anion sensing exemplify the impact of innovative research in chemistry. His patents reflect a dedication to addressing significant health and environmental challenges through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…